Who diagnoses Ehlers-Danlos (EDS) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Ehlers-Danlos Syndrome

Ehlers-Danlos syndrome (EDS) is primarily diagnosed by specialists with expertise in connective tissue disorders, including geneticists, rheumatologists, or specialized multidisciplinary teams, with gastroenterologists increasingly playing a role in identifying and referring patients with hypermobile EDS. 1

Initial Assessment and Screening

  • Gastroenterologists often serve as initial screeners for hypermobile EDS (hEDS) when patients present with disorders of gut-brain interaction (DGBI) and should:

    • Inquire about joint hypermobility
    • Incorporate the Beighton score as a screening tool for joint hypermobility 1
    • Apply 2017 diagnostic criteria for hEDS when the screen is positive
    • Refer to appropriate specialists when indicated 1
  • The Beighton scale evaluates:

    • Passive extension of little fingers beyond 90 degrees
    • Passive apposition of thumbs to forearm
    • Hyperextension of elbows beyond 10 degrees
    • Hyperextension of knees beyond 10 degrees
    • Forward flexion of trunk with knees extended (palms to floor) 2

Diagnostic Pathway

For Hypermobile EDS (most common type):

  1. Clinical assessment using the 2017 diagnostic criteria checklist
  2. Exclusion of other conditions presenting with joint hypermobility
  3. Referral to genetics specialists for definitive diagnosis 3

For Vascular EDS (most serious type):

  1. Targeted genetic testing for the COL3A1 gene
  2. Non-invasive vascular imaging to assess for arterial abnormalities
  3. Avoidance of invasive diagnostic procedures due to tissue fragility 2

Specialist Involvement

Different specialists may be involved in EDS diagnosis depending on the subtype and presenting symptoms:

  • Geneticists: Provide definitive diagnosis and genetic counseling, especially for types with known genetic mutations 4
  • Rheumatologists: Evaluate joint hypermobility and musculoskeletal symptoms
  • Cardiologists/Vascular specialists: Assess vascular manifestations, particularly in vascular EDS 2
  • Gastroenterologists: Screen for hEDS in patients with DGBI and evaluate for associated conditions like POTS and MCAS 1

Associated Conditions Requiring Specialized Assessment

  • Postural Orthostatic Tachycardia Syndrome (POTS):

    • Testing through postural vital signs (symptomatic increase in heart rate ≥30 beats/min with 10 minutes of standing)
    • Referral to cardiology or neurology when indicated 1
  • Mast Cell Activation Syndrome (MCAS):

    • Testing should be targeted to patients with clinical manifestations involving 2+ physiological systems
    • Serum tryptase levels collected at baseline and 1-4 hours following symptom flares
    • Increases of 20% above baseline plus 2 ng/mL indicate mast cell activation 1

Common Pitfalls in Diagnosis

  • Failure to recognize EDS due to overlapping symptoms with other conditions
  • Overreliance on genetic testing (especially for hEDS which has no known genetic marker)
  • Inadequate assessment of vascular complications in suspected vascular EDS
  • Failure to refer to appropriate specialists for definitive diagnosis 5, 6

Key Considerations

  • EDS diagnosis remains challenging due to overlapping symptoms between subtypes
  • The Villefranche classification and associated criteria are recommended for diagnosis 5
  • Accurate diagnosis is crucial for appropriate management, prevention of complications, and genetic counseling 7
  • Multidisciplinary assessment is often necessary for comprehensive evaluation and management 2

Remember that early recognition and appropriate referral by primary care physicians and specialists can help prevent devastating complications, particularly in vascular EDS where arterial and organ rupture can be life-threatening 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vascular Ehlers-Danlos Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Ehlers-Danlos syndrome--diagnosis and subclassification].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006

Research

Ehlers-Danlos syndrome--a historical review.

British journal of haematology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.